Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
1995
ISSN/ISBN: 0047-1852 PMID: 7563904 Document Number: 440950
Document emailed within 1 workday
Related Documents
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Kaji, K.; Unoura, M.; Kobayashi, K.; Nakanuma, Y. 1994: Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1865-1868
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Ohnishi, K.; Nomura, F.; Nakano, M. 1991: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status American Journal of Gastroenterology 86(8): 1041-1049
Paul, S.; Tabassum, S.; Islam, M.N. 2004: Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection Bangladesh Medical Research Council Bulletin 30(2): 71-77
Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Carreño, V.; Porres, J.C.; Ruiz-Moreno, M.; Gutiez, J.; Bartolomé, F.J. 1991: A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 24-28
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Ueda, T.; Chung, H.; Kudo, M. 2011: Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 319-324
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Chu, C-Jen.; Wang, Y-Jen.; Hwang, S-Jang.; Lu, R-Hwa.; Chang, F-Young.; Chang, C-Yu.; Yang, Y-Chun.; Lee, S-Dong. 2007: Kinetics of hepatitis C virus RNA load during pegylated interferon plus ribavirin therapy in Treatment-naive Chinese patients Hepato-Gastroenterology 54(75): 866-870
Moulin, V.; Harzic, M.; Doll, J.; Dubeaux, B.; Ghnassia, J.C.; Andrieu, J. 1996: Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C Pathologie-Biologie 44(5): 468-472
Hamidah, A.; Yong, J.F.; Zulkifli, H.I.; Jamal, R. 2002: Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia Medical Journal of Malaysia 57(3): 353-356
Cheung, R.C.; Keeffe, E.B. 1997: Hepatitis G virus: clinical relevance and responsiveness to interferon American Journal of Gastroenterology 92(11): 1957-1959
Fernández, B.; Basaras, M.; Blanco, S.; Sánchez, S.; Arrese, E.; de las Heras, B.; Cisterna, R. 2003: Hepatitis C virus variability and interferon-mediated pathway inhibition Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 16(3): 325-329
Taillan, B.; Ferrari, P.; Fuzibet, J.G.; Ferrari, E.; Quaranta, J.F.; Dujardin, P. 1991: Mixed cryoglobulinemia in hepatitis C virus infection. Value of interferon therapy Presse Medicale 20(29): 1392-1393